Download Sponsored Seminars - WOC2014 Tokyo Exhibition Guide

 IMS-FR-03
Morning Seminar Sponsored by HOYA Surgical Optics (HOYA CORPORATION Medical Division)
7:30-8:30
Room 5 (Hall D7 / Tokyo International Forum)
Strategic Approach to Astigmatism Correction
Chair: Shigeru Kinoshita
Speakers: Ludger Hanneken, Kazuno Negishi, Shigeru Kinoshita
In recent years, extraordinary developments have been made on diagnostics and operative tools to refine astigmatism
correction outcomes. Surgical options to correct astigmatism are also growing rapidly such as the advent of new toric IOLs
and the femtosecond laser for arcuate corneal incisions at the time of cataract surgery.
The next question would be what kinds of approach should be taken to maximize outcome? Many options are available
today; however it is essential to make appropriate choice of approach.
In this seminar, three expert doctors will share clinical pearls in the astigmatism correction including diagnostics tools and
toric IOL experiences.
IMS-FR-04
Morning Seminar
7:30-8:30
Sponsored Seminars
Friday, April 4
Sponsored by Bausch + Lomb, Inc.
Room 8 (G701 / Tokyo International Forum)
New Age Technology: Redefining Cataract & Refractive Surgery
Chair: Manfred Tetz
Speakers: Chee Soon Phaik, Robert Ang, Manfred Tetz
In this “Redefining Cataract and Refractive Surgery” symposium, we are pleased to have Prof CHEE Soon Phaik to share
with us on her special interest in managing complicated cataract cases with the VICTUSTM femtosecond laser and how it
has bring about unique advantages to these cases. Dr Robert Ang who has started using the latest excimer laser will also
be sharing with us his clinical experience with the TENEOTM 317 and how the excimer technology has evolved from the 217
to the current sleek and sexy machine. In concluding the symposium, Prof Manfred Tetz will be presenting on the material
design for the enVistaTM hydrophobic acrylic IOL.
IMS-FR-05
Morning Seminar
7:30-8:30
Sponsored by Pfizer Japan Inc.
Room 19 (Botan / Imperial Hotel)
The Best Way to Enjoy a Morning Buffet; Macular Disease
Chair: Shiho Kunimatsu-Sanuki
Speakers: Fumi Gomi, Chikako Suto
The best way to enjoy a morning buffet is to sample and choose only the most beautifully arranged items.
Macular disease is directly linked to patients’ quality of life. Recently, the presence of new diagnostic imaging devices
and medicines has continued to expand into the medical marketplace. Although ophthalmic fundus imaging plays an
important role in the diagnosis and classification of macular diseases and in monitoring treatment, the use of these
techniques and treatments depends on each ophthalmologist, like guests at a morning buffet.
In this course two experts will introduce their own “recipes”. Let’s study these delicious new ideas on how to manage
macular disease and diabetic macular edema.
413
WOC2014
Sponsored Seminars
Tokyo | April 2–6
WOC2014 Tokyo
Friday, April 4
ILS-FR-17
Lunch Seminar
12:15-13:15
Sponsored by Novartis Pharma AG
Room 2 (Hall C / Tokyo International Forum)
Ranibizumab: Transformational Outcomes in Patients with DME and RVO
Chairs: Yuichiro Ogura, José Cunha-Vaz
Speakers: Yuichiro Ogura, José Cunha-Vaz, Ian Pearce, Christian Prünte
It is increasingly clear that, in DME and RVO, early-stage pathology is driven by VEGF. Consequently, physicians should
endeavor to initiate early treatment using anti-VEGF agents. Comorbidities in patients with DME and RVO may mandate
the use of anti-VEGF treatments with minimal systemic exposure to optimize the benefit-risk ratio. Data from recent clinical
trials of ranibizumab demonstrate significant visual and anatomic improvements and minimal systemic exposure with an
individualized treatment regimen. With the wealth of available evidence and its well-established safety profile, ranibizumab
is a preferred option in the treatment of patients with DME and RVO (both BRVO and CRVO).
ILS-FR-18
Lunch Seminar
Cancelled
ILS-FR-19
Lunch Seminar Sponsored by SENJU PHARMACEUTICAL CO.,LTD. / ALLERGAN, INC.
12:15-13:15
Room 4 (Hall B7(2) / Tokyo International Forum)
Evidence of Neuroprotection in Topical Treatment
Chairs: Makoto Araie, Robert N. Weinreb
Speakers: Hidenobu Tanihara, David S. Greenfield, Ki-Ho Park
Approaches to neuroprotection include identifying exogenous agents that alleviate neuronal damage or upregulate
causative intracellular processes. Several topical anti-glaucoma agents reportedly show neuroprotective effects in vitro,
particularly brimonidine that is neuroprotective in several experimental systems. Moreover, topical brimonidine 0.2%
better preserved visual field than timolol 0.5% in the randomized double masked Low-pressure Glaucoma Treatment
Study (LoGTS). In this symposium, the pathophysiology of optic nerve damage and its amelioration via neuroprotection,
particularly with brimonidine, will be addressed.
414
ILS-FR-20
Lunch Seminar
Sponsored by Santen Pharmaceutical Co.,Ltd.
12:15-13:15
Room 5 (Hall D7 / Tokyo International Forum)
"A Clear Vision For Life®" - The Importance of Inflammation and Tear Film Stability in Dry Eye
Chairs: Kazuo Tsubota, Hyo Myung Kim, Zuguo Liu
Speakers: Xuguang Sun, Hungwon Tchah, Norihiko Yokoi
DEWS defines “dry eye” as a multifactorial disease affecting tears and the ocular surface that results in symptoms of
discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. It is accompanied by
increased osmolarity of the tear film and inflammation of the ocular surface.
However, the core mechanism of dry eye is situational and varies in accordance with each country’s occurrence. Therefore,
in this seminar the Asia Dry Eye Society will discuss in depth “the stability of the tear film and the inflammation brought
about by dry eye.”
ILS-FR-21
Lunch Seminar
Sponsored Seminars
Friday, April 4
Sponsored by Heidelberg Engineering GmbH
12:15-13:15
Room 6 (Hall D5 / Tokyo International Forum)
From Clinical Examination of the Optic Disc to the Clinical Examination of the Optic Nerve Head:
A Paradigm Change
Chair: Goji Tomita
Speakers: Claude F. Burgoyne, Balwantray C. Chauhan, Masanori Hangai
During the symposium the presenters will review and interpret the anatomy of the optic nerve head (ONH) detected with
spectral-domain optical coherence tomography (SD OCT) pertaining to the clinical examination of the optic disc and to
propose that a paradigm change for clinical assessment of the ONH is necessary. The paradigm change is anchored to
the eye-specific anatomy and geometry of the ONH and fovea. The approach is designed to enhance the accuracy and
consistency of rim width, as well as of peripapillary and macular intraretinal thickness measurements.
ILS-FR-22
Lunch Seminar
12:15-13:15
Sponsored by Carl Zeiss Meditec AG
Room 8 (G701 / Tokyo International Forum)
21st Century Diagnostic Testing in Glaucoma Management: Where We are and Where We are Going.
Chairs: Aiko Iwase, Felipe Medeiros
Speakers: Robert Fechtner, Christopher Leung, David Friedman, Felipe Medeiros
Join us for a dynamic presentation on current glaucoma diagnostics as well as emerging technologies led by renowned
glaucoma experts.
You will learn evolving applications that will combine structural and functional findings into a single combined metric
that may simplify both diagnosis and change analysis, and also emerging OCT technologies that could bring entirely new
techniques for patient management.
415
WOC2014
Sponsored Seminars
Tokyo | April 2–6
WOC2014 Tokyo
Friday, April 4
ILS-FR-23
Lunch Seminar
12:15-13:15
Sponsored by NIDEK CO., LTD.
Room 9 (G602 / Tokyo International Forum)
Diagnostics for Premium IOL Surgery
Chair: Sheraz M. Daya
Speakers: Sheraz M. Daya, Fam Han Bor, Damien Gatinel
With improvements in surgical technique and technology including high performance and premium intraocular lens
implants, there is an increased demand for perfect refractive outcomes following cataract and refractive lens exchange
surgery. To assist the surgeon, new diagnostic devices have been introduced to facilitate planning preoperatively and intraoperatively.
Three surgeons invited from the UK, France and Singapore will present their personal preoperative diagnostic work up and
the use of technology at all stages in the patient pathway to optimise outcomes. The overall focus of this symposium will
be on how modern diagnostics can improve surgical outcomes and postoperative visual quality without compromising
efficiency and safety. The pathways presented and discussed promise to set the standards for premium IOL surgery.
ILS-FR-24
Lunch Seminar
12:15-13:15
Sponsored by STAAR Japan Inc.
Room 10 (G610 / Tokyo International Forum)
Premium Refractive Surgery & Preserving the Cornea for the Future
Chair: Kimiya Shimizu
Speakers: Kimiya Shimizu, Robert P. Rivera, Alaa El-Danasoury, Sri Ganesh, Ningli Wang
DATE : Friday April 4, 2014, 12:15-13:15
Venue: Room G610, Tokyo International Forum
Moderator and Keynote Lecture:
Dr. Kimiya Shimizu (Japan) / Seven Years of Premium Outcomes after Visian ICL with CentraFLOW Featuring KS-AquaPORT
Speakers:
Dr. Robert P. Rivera (USA) / Dry Eye -A Forgotten Hassle Post-Lasik
Dr. Alaa El-Danasoury (Saudi Arabia) / The Premium Role of Phakic IOLs in My Practice
Dr. Sri Ganesh (India) / Correcting Myopic Astigmatism While Preserving the Cornea
Dr. Ningli Wang (China) / Long-Term Clinical Outcomes of Visian ICL in China
ILS-FR-25
Lunch Seminar
12:15-13:15
Sponsored by TOMEY CORPORATION
Room 11 (G502 / Tokyo International Forum)
The Present and the Future of Optical Coherence Tomography for Anterior Segment Evaluation
Chair: Shigeru Kinoshita
Speakers: Naoyuki Maeda, Tin Aung
The precise, quantitative analysis of anterior segment shape is essential for corneal irregularity, primary glaucoma and
cataract surgery. For instance, the applicable clinical situations are the corneal shape evaluation of keratoconus suspected,
the evaluation of anterior chamber angle shape in primary angle-closure glaucoma, and the IOL calculation in patients
with post-refractive surgeries including LASIK, and moderate/severe corneal astigmatism.
Several optical coherence tomographies are used in these circumstances. Among them, the swept source optical
coherence tomography (SSOCT, CASIA, Tomey Corporation) is a novel imaging device that employs a 1310 nm swept laser,
which is the state of the art OCT device for the anterior-segment quantitative analysis mentioned above.
In this seminar, we invite Dr. Naoyuki Maeda, Japan, and Dr. Tin Aung, Singapore, two distinguished clinician- scientists in
the world, to understand the effectiveness of SSOCT. We hope you will enjoy this seminar.
416
ILS-FR-26
Lunch Seminar
12:15-13:15
Sponsored by Pfizer Japan Inc.
Room 12 (G510 / Tokyo International Forum)
Valuable Glaucoma Medical Treatment from Tomorrow
Chair: Tetsuya Yamamoto
Speakers: Makoto Aihara, Takeo Fukuchi
The main treatment strategy for glaucoma is medical IOP reduction. Since there’re so many eyedrops, selection of them
with full consideration of individual conditions is of utmost importance. We have invited two distinguished glaucoma
specialists to discuss this particular issue. Dr. Makoto Aihara will speak on how to choose the first-line drug with special
emphasis on adherence. Prof. Takeo Fukuchi will talk on the selection of second-line drugs and emphasize the importance
of long-term visual outcome. The Chairman believes that this seminar is worthwhile for better understanding of the
practical glaucoma management.
ILS-FR-27
Lunch Seminar
12:15-13:15
Sponsored Seminars
Friday, April 4
Sponsored by Bayer HealthCare
Room 17 (Peacock (East) / Imperial Hotel)
Diabetic Macular Edema: A Look at Best Practices for Optimal Visual Acuity
Chairs: Quan Dong Nguyen, Diana Do
Speakers: Hiroko Terasaki, Tien Yin Wong
Diabetic macular edema (DME) is a complex yet common disease, and a leading cause of vision loss in patients with
diabetic retinopathy (DR). While several therapies for DME are currently available, including macular laser photocoagulation,
corticosteroids, and anti-VEGF agents, clinical data on existing and emerging agents is continuously evolving. New
information, coupled with the lack of consensus regarding the optimal management of DME, has contributed to gaps
in patient management. Thus, this activity is intended to provide retina specialists with strategies for evaluating and
incorporating data from clinical trials into practice in order to improve the management of patients with DME.
ILS-FR-28
Lunch Seminar
12:15-13:15
Sponsored by Topcon Corporation
Room 18 (Peacock (West) / Imperial Hotel)
Clinical Advantages of Swept Source OCT and New Photo-Thermal Stimulation with PASCAL Laser
Chair: Fumio Shiraga
Speakers: Pravin Dugel, Richard Spaide
In this symposium, two new technological advances will be explained and their clinical advantages will be discussed. OCT
has become the clinical standard of care in Ophthalmology. Topcon is the only company to introduce the 3rd generation
OCT, based on swept-source technology. The advantages this new OCT provides over time domain and Fourier Domain
OCT will be discussed. Another clinical breakthrough has occurred in laser treatment. The idea of placing visible burns
to treat DME and DR patients is being replaced with a new, non-damaging photo-thermal stimulation technique that is
clinically effective without damaging the retina and destroying photoreceptors.
417
WOC2014
Sponsored Seminars
Tokyo | April 2–6
WOC2014 Tokyo
Friday, April 4
ILS-FR-29
Lunch Seminar
Sponsored by Otsuka Pharmaceutical Co.,Ltd.
12:15-13:15
Room 19 (Botan / Imperial Hotel)
Reshaping the Scientific Approach to Eye Fatigue-3rd Stage
Chair: Kohji Nishida
Speakers: Shizuka Koh, Yuichi Hori, Masayoshi Kajita
Eye fatigue is very common in daily life, and its treatment in daily practice may in some instances provide only limited
outcome, promoting patient dissatisfaction.
This 3rd session, titled “Reshaping the Scientific Approach to Eye Fatigue-3rd Stage,” will focus on present situations, causes,
and treatments for eye fatigue from new perspectives.
Recent changes in lifestyles have increased eye overuse, augmenting complaints of the symptom. Therefore, ophthalmic
practice should aim to enhance quality of vision in such circumstances. In this session, eye fatigue will be extensively
reviewed, and it will surely help tomorrow’s practice. I look forward to your participation.
ILS-FR-30
Lunch Seminar
Sponsored by Bausch + Lomb, Inc.
12:15-13:15
Room 20 (Kiku / Imperial Hotel)
Maximizing Patient Outcomes With Stellaris PC
Chair: Taiji Sakamoto
Speakers: Takashi Kitaoka, Faisal Fayyad, Yannick Le Mer
Upcoming Next Generation Stellaris PC, the ideal choice for cataract, VR and combined procedures now refined with
customer driven enhancements, full laser integration and greater procedural versatility. New high performance Entry Site
Alignment (ESA) valved cannula system provides a secure and stable environment for improved IOP maintenance and
enhanced procedural versatility. In this symposium, we are honored to have Prof Taiji Sakamoto as the Chairman, along
with renowned overseas surgeons, Dr Faisal Fayyad, who will be sharing on the management of complicated VR surgeries
with the Stellaris PC. Local Japanese surgeon Prof Takashi Kitaoka will be sharing the patient outcomes and clinical
experience with the Stellaris PC focusing on the clinical benefits of color filters for tissue visualization. Dr. Yannick Le Mer
from Paris will be sharing with us for his clinical experience with next generation Stellaris PC system.
ILS-FR-31
Lunch Seminar
Sponsored by HOYA Surgical Optics (HOYA CORPORATION Medical Division)
12:15-13:15
Room 22 (Hikari / Imperial Hotel)
Pearls for Management of Complicated Cataract Cases - Techniques, Devices, and Complication
Management
Chair: Tetsuro Oshika
Speakers: Manfred Tetz, Toshiyuki Nagamoto, Tat Keong Chan, Tetsuro Oshika
Phacoemulsification in cases with preoperative comorbidity poses difficulty in surgery and suboptimal visual outcomes.
Recently, several new devices, techniques and surgical strategies have become available to facilitate cataract surgery in
complicated cases. Proper usage of these skills and instrumentations, such as use of capsular tension ring and application
of appropriate anti-infectious prophylaxis, is of critical importance to conquer difficult cataract surgery cases. This seminar
will include specific surgical steps and planning to improve the outcome of cataract surgery in cases with complex
preoperative problems.
418
ILS-FR-32
Lunch Seminar
12:15-13:15
Sponsored by Alcon Laboratories, Inc
Room 23 (Fuji / Imperial Hotel)
Advancing Cataract Surgical Outcomes via Next Generation Technology
Chair: Ronald Yeoh
Speakers: Michael Lawless, Michael Knorz, David Allen
No description provided.
ILS-FR-33
Lunch Seminar
12:15-13:15
Sponsored Seminars
Friday, April 4
Sponsored by Optos
Room 24 (Miyabi / Imperial Hotel)
Ultra-Widefield Retinal Imaging a New Standard of Care: Clinical Applications & Case Studies
Chair: Sebastian Wolf
Speakers: Srinivas Sadda, Seenu M. Hariprasad, Quan Nygen, Szilard Kiss
Optos is continuing to expand the clinical applications of optomap Ultra-widefield Imaging. Studies demonstrate that
significant clinical changes in diseases such as diabetic retinopathy, retinal vein occlusion, degenerative and inflammatory
disease occur in the peripheral retina. Thus, the ability to image and monitor the entire retina with Ultra-widefield Imaging
is crucially important. Additionally, targeted photocoagulation guided by Ultra-widefield imaging may work together
with pharmacological intervention to aid improved outcomes in Diabetic Macular Oedema. This symposium will educate
delegates on the role of Optos technology to enable a new standard of care to be delivered that will lead to more effective
detection and treatment of the retinal disease.
419